Article Details

Merck expects Covid treatment pill sales of up to $6 billion in 2022 - CNBC

Retrieved on: 2022-02-04 08:07:25

Tags for this article:

Click the tags to see associated articles and topics

Merck expects Covid treatment pill sales of up to $6 billion in 2022 - CNBC. View article details on hiswai:

Excerpt

CEO Rob Davis said Merck is on track to fulfill its commitment in the coming days of delivering 3.1 million courses of its Covid treatment pill ...

Article found on: www.cnbc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up